Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Inhibidores de monoaminooxidasa B versus otros agentes dopaminérgicos en la enfermedad de Parkinson temprana

Información

DOI:
https://doi.org/10.1002/14651858.CD006661.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 octubre 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos del movimiento

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Robert Caslake

    Medecine & Therapeutics, University of Aberdeen, Aberdeen, UK

  • Angus Macleod

    Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK

  • Natalie Ives

    Birmingham Clinical Trials Unit, School of Cancer Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, UK

  • Rebecca Stowe

    Birmingham Clinical Trials Unit, School of Cancer Sciences, Robert Aitken Institute, University of Birmingham, Birmingham, UK

  • Carl Counsell

    Correspondencia a: Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK

    [email protected]

Contributions of authors

AM, RC, CC developed the protocol with comments from NI and RS. RC and AM searched for the trials supplemented by searches conducted by RS. RC checked them for eligibility with CC, extracted the data (double checked by CC) and wrote the first draft of the review. CC contacted trial authors for additional details. All authors commented on the manuscript.

Sources of support

Internal sources

  • University of Aberdeen, UK.

  • University of Birmingham, UK.

External sources

  • No sources of support supplied

Declarations of interest

CC, NI, and RS are all either recruiting into or involved in running the PD MED trial.

Acknowledgements

We would like to thank Professor Cristina Sampaio for providing data from the PARJUPAR study. If there are any relevant completed or ongoing trials that we have omitted from the review please contact Carl Counsell.

Version history

Published

Title

Stage

Authors

Version

2009 Oct 07

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

Review

Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell

https://doi.org/10.1002/14651858.CD006661.pub2

2009 Jul 08

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

Protocol

Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell

https://doi.org/10.1002/14651858.CD006661

Differences between protocol and review

None